• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溃疡性结肠炎中具有促炎和DNA损伤活性的潜在血清生物标志物的发现与验证:一项全面的非靶向代谢组学研究

Discovery and Validation of Potential Serum Biomarkers with Pro-Inflammatory and DNA Damage Activities in Ulcerative Colitis: A Comprehensive Untargeted Metabolomic Study.

作者信息

Li Mingxiao, Zhang Rui, Xin Mingjie, Xu Yi, Liu Shijia, Yu Boyang, Zhang Boli, Liu Jihua

机构信息

Jiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China.

Department of Pharmacy, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.

出版信息

Metabolites. 2022 Oct 20;12(10):997. doi: 10.3390/metabo12100997.

DOI:10.3390/metabo12100997
PMID:36295899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9609580/
Abstract

Ulcerative colitis is a type of non-specific inflammatory bowel disease with unclear etiology. It is considered a progressive disease with risks of bowel motility disorders, anorectal dysfunction, and even colorectal cancer. Commonly used diagnostic markers have poor specificity and cannot predict the development of ulcerative colitis. In this study, 77 serum samples (31 patients, 46 healthy controls) were analyzed using high performance liquid chromatography-quadrupole time-of-flight mass spectrometry and 31 metabolites with significant level changes were found, revealing the relationship of ulcerative colitis to disturbed glutathione metabolism and caffeine metabolism. In addition, pyroglutamic acid, a biomarker of cervical cancer and gastric cancer, was identified with elevated levels in the serum of ulcerative colitis patients. The role of pyroglutamic acid was further analyzed, and the results indicated its positive correlation with the upregulation of inflammatory factors and increased levels of phosphorylated histone H2AX (H2AX) in IEC-6 cells, which are related to DNA damage. All these results suggest that pyroglutamic acid is not only a biomarker for distinguishing ulcerative colitis status, but that it is also a potential effective metabolite that promotes the transformation of ulcerative colitis to colorectal cancer.

摘要

溃疡性结肠炎是一种病因不明的非特异性炎症性肠病。它被认为是一种进展性疾病,存在肠道运动障碍、肛肠功能障碍甚至结直肠癌的风险。常用的诊断标志物特异性较差,无法预测溃疡性结肠炎的发展。在本研究中,使用高效液相色谱-四极杆飞行时间质谱法分析了77份血清样本(31例患者,46例健康对照),发现31种代谢物水平有显著变化,揭示了溃疡性结肠炎与谷胱甘肽代谢和咖啡因代谢紊乱的关系。此外,焦谷氨酸作为宫颈癌和胃癌的生物标志物,在溃疡性结肠炎患者血清中水平升高。进一步分析了焦谷氨酸的作用,结果表明其与炎症因子上调以及IEC-6细胞中与DNA损伤相关的磷酸化组蛋白H2AX(H2AX)水平升高呈正相关。所有这些结果表明,焦谷氨酸不仅是区分溃疡性结肠炎状态的生物标志物,而且是促进溃疡性结肠炎向结直肠癌转变的潜在有效代谢物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c5/9609580/98e9ae256206/metabolites-12-00997-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c5/9609580/bc596bf8e058/metabolites-12-00997-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c5/9609580/cd1f50537fa1/metabolites-12-00997-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c5/9609580/e22b3dcf0602/metabolites-12-00997-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c5/9609580/98e9ae256206/metabolites-12-00997-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c5/9609580/bc596bf8e058/metabolites-12-00997-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c5/9609580/cd1f50537fa1/metabolites-12-00997-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c5/9609580/e22b3dcf0602/metabolites-12-00997-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c5/9609580/98e9ae256206/metabolites-12-00997-g004.jpg

相似文献

1
Discovery and Validation of Potential Serum Biomarkers with Pro-Inflammatory and DNA Damage Activities in Ulcerative Colitis: A Comprehensive Untargeted Metabolomic Study.溃疡性结肠炎中具有促炎和DNA损伤活性的潜在血清生物标志物的发现与验证:一项全面的非靶向代谢组学研究
Metabolites. 2022 Oct 20;12(10):997. doi: 10.3390/metabo12100997.
2
Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers.比较肠易激综合征患者、溃疡性结肠炎患者和健康对照者的代谢组学特征:对病理生理学和潜在生物标志物的新认识。
Aliment Pharmacol Ther. 2019 Mar;49(6):723-732. doi: 10.1111/apt.15141. Epub 2019 Jan 31.
3
[Gut-liver axis in inflammatory bowel disease. A retrospective study].[炎症性肠病中的肠-肝轴。一项回顾性研究]
Orv Hetil. 2017 Jul;158(26):1014-1021. doi: 10.1556/650.2017.30781.
4
Using serum peptidomics to discovery the diagnostic marker for different stage of ulcerative colitis.利用血清肽组学发现溃疡性结肠炎不同阶段的诊断标志物。
J Pharm Biomed Anal. 2021 Jan 30;193:113725. doi: 10.1016/j.jpba.2020.113725. Epub 2020 Oct 28.
5
Chronic inflammatory bowel disease and cancer.慢性炎症性肠病与癌症
Hepatogastroenterology. 2000 Jan-Feb;47(31):57-70.
6
INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS.白细胞介素-6、C反应蛋白与白细胞介素-6(-174)G/C多态性在克罗恩病和溃疡性结肠炎发病机制中的相互作用
Acta Clin Croat. 2020 Mar;59(1):67-80. doi: 10.20471/acc.2020.59.01.09.
7
Serum IL-17 and IL-6 increased accompany with TGF-β and IL-13 respectively in ulcerative colitis patients.在溃疡性结肠炎患者中,血清白细胞介素-17(IL-17)和白细胞介素-6(IL-6)分别与转化生长因子-β(TGF-β)和白细胞介素-13(IL-13)伴随升高。
Int J Clin Exp Med. 2014 Dec 15;7(12):5498-504. eCollection 2014.
8
Piper umbellatum L. (Piperaceae): Phytochemical profiles of the hydroethanolic leaf extract and intestinal anti-inflammatory mechanisms on 2,4,6 trinitrobenzene sulfonic acid induced ulcerative colitis in rats.水醇提佩兰(胡椒科)叶提取物的植物化学成分分析及其对 2,4,6-三硝基苯磺酸诱导的大鼠溃疡性结肠炎的肠道抗炎机制。
J Ethnopharmacol. 2020 May 23;254:112707. doi: 10.1016/j.jep.2020.112707. Epub 2020 Feb 27.
9
Untargeted Metabolomics and Inflammatory Markers Profiling in Children With Crohn's Disease and Ulcerative Colitis-A Preliminary Study.克罗恩病和溃疡性结肠炎患儿非靶向代谢组学和炎症标志物分析——一项初步研究。
Inflamm Bowel Dis. 2019 Jun 18;25(7):1120-1128. doi: 10.1093/ibd/izy402.
10
A high degree of aneuploidy, loss of p53 gene, and low soluble p53 protein serum levels are detected in ulcerative colitis patients.在溃疡性结肠炎患者中检测到高度非整倍体、p53基因缺失以及低水平的可溶性p53蛋白血清水平。
Dis Colon Rectum. 2004 Mar;47(3):304-13. doi: 10.1007/s10350-003-0048-z.

引用本文的文献

1
Gut microbiota and metabolome signatures in obese and normal-weight patients with colorectal tumors.肥胖和体重正常的结直肠肿瘤患者的肠道微生物群和代谢组特征
iScience. 2025 Mar 13;28(4):112221. doi: 10.1016/j.isci.2025.112221. eCollection 2025 Apr 18.
2
Metabolomics identifies plasma biomarkers of localized radiation injury.代谢组学鉴定局部辐射损伤的血浆生物标志物。
Sci Rep. 2025 Jan 16;15(1):2166. doi: 10.1038/s41598-025-85717-5.
3
Colonic dysmotility regulated by downregulation of PDGFRα+ cells / SK3 channel in DSS-induced colitis mice.

本文引用的文献

1
Identification of Insulin Resistance Biomarkers in Metabolic Syndrome Detected by UHPLC-ESI-QTOF-MS.通过超高效液相色谱-电喷雾电离-四极杆飞行时间质谱法检测代谢综合征中胰岛素抵抗生物标志物
Metabolites. 2022 Jun 1;12(6):508. doi: 10.3390/metabo12060508.
2
Analysis of Serum Proteome after Treatment of Osteoporosis with Anabolic or Antiresorptive Drugs.用促合成或抗吸收药物治疗骨质疏松症后血清蛋白质组分析
Metabolites. 2022 Apr 28;12(5):399. doi: 10.3390/metabo12050399.
3
Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in Dogs.
在葡聚糖硫酸钠(DSS)诱导的结肠炎小鼠中,由血小板衍生生长因子受体α(PDGFRα)+细胞/小电导钙激活钾通道3(SK3)通道下调所调节的结肠动力障碍
PLoS One. 2024 Dec 17;19(12):e0312413. doi: 10.1371/journal.pone.0312413. eCollection 2024.
4
Impact of Mild COVID-19 History on Oral-Gut Microbiota and Serum Metabolomics in Adult Patients with Crohn's Disease: Potential Beneficial Effects.轻度新冠病史对成年克罗恩病患者口腔-肠道微生物群和血清代谢组学的影响:潜在益处
Biomedicines. 2024 Sep 14;12(9):2103. doi: 10.3390/biomedicines12092103.
5
Patient subtyping analysis of baseline multi-omic data reveals distinct pre-immune states associated with antibody response to seasonal influenza vaccination.基于多组学的基线数据分析揭示了与季节性流感疫苗接种后抗体反应相关的不同初始免疫状态。
Clin Immunol. 2024 Sep;266:110333. doi: 10.1016/j.clim.2024.110333. Epub 2024 Jul 30.
6
Systematic review of metabolomic alterations in ulcerative colitis: unveiling key metabolic signatures and pathways.溃疡性结肠炎代谢组学改变的系统评价:揭示关键代谢特征和途径
Therap Adv Gastroenterol. 2024 Mar 29;17:17562848241239580. doi: 10.1177/17562848241239580. eCollection 2024.
7
Does caffeine have a double-edged sword role in inflammation and carcinogenesis in the colon?咖啡因在结肠炎症和致癌过程中是否具有双刃剑作用?
Intest Res. 2023 Jul;21(3):306-317. doi: 10.5217/ir.2022.00118. Epub 2023 Apr 20.
非靶向代谢组学鉴定出一组用于诊断犬膀胱尿路上皮癌的尿液生物标志物,并与伴或不伴尿路感染的尿石症进行比较。
Metabolites. 2022 Feb 24;12(3):200. doi: 10.3390/metabo12030200.
4
Recent advances in metabolomics analysis for early drug development.代谢组学分析在新药早期开发中的最新进展。
Drug Discov Today. 2022 Jun;27(6):1763-1773. doi: 10.1016/j.drudis.2022.02.018. Epub 2022 Feb 24.
5
Incidence and Risk Factors of Cancer in the Anal Transitional Zone and Ileal Pouch following Surgery for Ulcerative Colitis and Familial Adenomatous Polyposis.溃疡性结肠炎和家族性腺瘤性息肉病手术后肛管移行区和回肠袋的癌症发病率及危险因素
Cancers (Basel). 2022 Jan 21;14(3):530. doi: 10.3390/cancers14030530.
6
What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented?溃疡性结肠炎的疾病进展是什么样的,它如何预防?
Gastroenterology. 2022 Apr;162(5):1396-1408. doi: 10.1053/j.gastro.2022.01.023. Epub 2022 Jan 29.
7
Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitis.溃疡性结肠炎肠道炎症的监测及复发预测
Scand J Gastroenterol. 2022 May;57(5):513-524. doi: 10.1080/00365521.2021.2022193. Epub 2022 Jan 7.
8
Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management.炎症性肠病相关结直肠癌:发病机制与处理
Gastroenterology. 2022 Mar;162(3):715-730.e3. doi: 10.1053/j.gastro.2021.10.035. Epub 2021 Oct 29.
9
Untargeted Plasma Metabolomic Profiling in Patients with Major Depressive Disorder Using Ultra-High Performance Liquid Chromatography Coupled with Mass Spectrometry.使用超高效液相色谱-质谱联用技术对重度抑郁症患者进行非靶向血浆代谢组学分析
Metabolites. 2021 Jul 20;11(7):466. doi: 10.3390/metabo11070466.
10
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.2020 年炎症性肠病循证临床实践指南。
J Gastroenterol. 2021 Jun;56(6):489-526. doi: 10.1007/s00535-021-01784-1. Epub 2021 Apr 22.